Mankind Pharma's successful story

• 52
• 0

1. Humble Beginnings: Founded in 1995 by R.C. Juneja and Ramesh Juneja in New Delhi.

2. Visionary Leadership: Juneja brothers' vision to make affordable medicines accessible to all.

3. Innovative Products: Introduced unique formulations, such as Manforce condoms and PregaNews pregnancy detection cards.

4. Expansion and Growth: Expanded product portfolio, increased distribution network, and entered new markets.

5. Diversification: Ventured into various therapeutic areas, including antibiotics, gastroenterology, and cardiology.

6. Quality Focus: Implemented strict quality control measures, earning ISO 9001 certification.

7. Brand Building: Created popular brands like Manforce, PregaNews, and Unwanted-72.

8. Awards and Recognition: Received numerous awards, including "Best Pharma Company" at the 2019 India Pharma Awards.

9. Sustainability Efforts: Implemented eco-friendly practices, reduced waste, and promoted rural healthcare.

10. Legacy and Leadership: Juneja brothers' leadership transformed Mankind into a leading pharma player, inspiring a new generation of entrepreneurs.

---

---

Today, Mankind Pharma is: - India's 4th largest pharma company - ₹35,000 crore+ turnover - Presence in over 20 countries - Employs over 14,000 people - Offers over 300 products across 14 therapeutic areas Mankind Pharma's success story is a testament to innovative products, quality focus, and visionary leadership. Mankind Pharma offers a wide range of products across various therapeutic areas, including:

1. Antibiotics: - Moxikind (Moxifloxacin) - Tetrakind (Tetracycline)

2. Gastroenterology: - Pantokind (Pantoprazole) - Sucrakind (Sucralfate)

3. Cardiology: - Telmikind (Telmisartan) - Amlodipine

4. Dermatology: - Kozikind (Ketoconazole) - Mometasone

5. Neurology: - Levokind (Levocetirizine) - Gabakind (Gabapentin)

6. Pain Management: - Tramakind (Tramadol) - Flumark (Flupirtine)

7. Contraceptives: - Manforce condoms - Unwanted-72 (Emergency contraceptive)

8. Obstetrics & Gynecology: - PregaNews (Pregnancy detection cards) - Mifegest (Mifepristone)

9. Oncology: - Cytokind (Cytarabine) - Gemkind (Gemcitabine)

10. Nutraceuticals: - Health OK (Multivitamin) - FlexiQ (Glucosamine and Chondroitin) Please note that products may vary by region and market.

Mankind Pharma continuously innovates and expands its product range to cater to evolving customer needs. Mankind Pharma's turnover was ₹8,749 crore for the financial year ending March 31, 2023, marking a 12% year-over-year increase ¹. The company's revenue from operations rose to ₹2,893 crore in Q1 FY25, a 12.2% year-over-year rise